Holen Sie sich die Stockscreener-App
2.38
2.06%
-0.05
Handel nachbörslich:
2.41
0.03
+1.26%
Schlusskurs vom Vortag:
$2.43
Offen:
$2.44
24-Stunden-Volumen:
444.42K
Relative Volume:
0.64
Marktkapitalisierung:
$133.94M
Einnahmen:
$76.19M
Nettoeinkommen (Verlust:
$-1.61M
KGV:
238.00
EPS:
0.01
Netto-Cashflow:
$28.98M
1W Leistung:
+3.93%
1M Leistung:
+16.10%
6M Leistung:
+267.85%
1J Leistung:
+101.69%
1-Tages-Spanne:
$2.32
$2.465
1-Wochen-Bereich:
$2.27
$2.475
52-Wochen-Spanne:
$0.5052
$3.22
Spero Therapeutics Inc Stock (SPRO) Company Profile
Firmenname
Spero Therapeutics Inc
Sektor
Branche
Telefon
857-242-1600
Adresse
675 MASSACHUSETTS AVENUE, CAMBRIDGE, MA
Vergleichen Sie SPRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRO
Spero Therapeutics Inc
|
2.38 | 136.75M | 76.19M | -1.61M | 28.98M | 0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-09-23 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-10-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-01-22 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Eingeleitet | Evercore ISI | Outperform |
| 2019-11-05 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-09 | Eingeleitet | Janney | Buy |
| 2018-02-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-11-27 | Eingeleitet | BofA/Merrill | Neutral |
| 2017-11-27 | Eingeleitet | Oppenheimer | Outperform |
| 2017-11-27 | Eingeleitet | Stifel | Buy |
Alle ansehen
Spero Therapeutics Inc Aktie (SPRO) Neueste Nachrichten
Why Spero Therapeutics Inc. stock is favored by pension fundsWeekly Stock Report & Low Volatility Stock Recommendations - newser.com
Is Spero Therapeutics Inc. stock vulnerable to regulatory risksWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Will Spero Therapeutics Inc. stock pay special dividendsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
How Spero Therapeutics Inc. stock compares to industry benchmarksQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Using flow based indicators on Spero Therapeutics Inc.Earnings Beat & Free Weekly Watchlist of Top Performers - newser.com
How to monitor Spero Therapeutics Inc. with trend dashboardsWeekly Market Report & High Accuracy Investment Signals - newser.com
How Spero Therapeutics Inc. stock reacts to inflationary pressuresMarket Movers & Fast Entry High Yield Tips - newser.com
Is Spero Therapeutics Inc. (2HA) stock undervalued historicallyJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
What earnings margins imply for Spero Therapeutics Inc. (2HA) stockQuarterly Profit Summary & High Win Rate Trade Tips - newser.com
Spero Therapeutics Inc. stock daily chart insightsJuly 2025 Retail & Fast Entry High Yield Tips - newser.com
Will Spero Therapeutics Inc. benefit from macro trendsEntry Point & AI Driven Stock Reports - newser.com
What MACD signals say about Spero Therapeutics Inc.Quarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
What analysts say about Spero Therapeutics Inc stockSupport and Resistance Levels & Free Unlock Hidden Market Opportunities - earlytimes.in
What Technical Resistance Could Cap Regis Industries Ltds UpsideMonthly Performance Summary & Free High Yield Portfolio Picks - earlytimes.in
Will Spero Therapeutics Inc. stock keep outperforming rivalsPortfolio Update Report & Risk Adjusted Swing Trade Ideas - newser.com
Will Spero Therapeutics Inc. stock sustain high P E ratiosEarnings Recap Report & Daily Profit Maximizing Tips - newser.com
Will breakout in Spero Therapeutics Inc. lead to full recoveryTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
What recovery options are there for Spero Therapeutics Inc.Weekly Loss Report & Free Real-Time Market Sentiment Alerts - newser.com
Spero Therapeutics, Inc. (NASDAQ:SPRO) Short Interest Down 42.5% in October - MarketBeat
How sustainable is Spero Therapeutics Inc. stock dividend payoutMarket Activity Summary & Expert Verified Stock Movement Alerts - newser.com
What does recent volatility data suggest for Spero Therapeutics Inc.Quarterly Market Summary & Stepwise Swing Trade Plans - newser.com
Published on: 2025-11-01 09:23:51 - newser.com
Will Spero Therapeutics Inc. stock recover after recent drop2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-31 10:27:16 - newser.com
Why Spero Therapeutics Inc. (2HA) stock is trending on social mediaWeekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Will Spero Therapeutics Inc. stock remain a Wall Street favoriteMarket Trend Summary & Entry Point Confirmation Alerts - newser.com
Why Spero Therapeutics Inc. (2HA) stock is listed among top recommendationsWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Published on: 2025-10-30 05:46:40 - newser.com
Finanzdaten der Spero Therapeutics Inc-Aktie (SPRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):